Rachel A. Stahler

Rachel A. Stahler is a declared insider at 2 companies (chief executive); the most frequent names are Organon & Co. and Neogenomics Inc. Between 28 May 2020 and 31 March 2026, the trades on record add up to 45 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 2 April 2026, the filings show an option exercise in Organon & Co. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.